XML 85 R72.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Guarantor and Non-Guarantor Financial Information, Comprehensive Income Statements (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Mar. 31, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME            
Net sales $ 356.3 $ 334.9   $ 711.6 $ 678.1  
Cost of products sold:            
Cost of products sold, excluding depreciation and amortization and other items 277.7 250.4   555.5 512.4  
Lower of cost or market inventory write-down 0.0 0.0 $ 4.9 0.0 4.9  
Unrealized loss (gain) on derivative instruments 11.9 (10.9)   (3.2) (14.9)  
Depreciation and amortization 9.5 9.0   19.1 17.7  
Selling, general, administrative, research and development 26.3 27.5   50.0 53.6  
Net periodic postretirement benefit cost relating to Salaried VEBA 1.1 0.9   2.2 1.7  
Gain on removal of Union VEBA net assets 0.0 0.0   (1.3) (0.1)  
Total selling, general, administrative, research and development 27.4 28.4   50.9 55.2  
Goodwill impairment 18.4 0.0   18.4 0.0 $ 0.0
Other operating charges, net 0.0 0.1   0.0 0.1  
Total costs and expenses 344.9 277.0   640.7 575.4  
Operating income 11.4 57.9   70.9 102.7  
Other (expense) income:            
Interest (expense) income (5.5) (5.5)   (11.1) (9.2)  
Other (expense) income, net 1.0 (10.7)   1.6 (10.4)  
Income before income taxes 6.9 41.7   61.4 83.1  
Income tax provision (2.2) (15.7)   (20.7) (30.8)  
Earnings in equity of subsidiaries 0.0 0.0   0.0 0.0  
Net income 4.7 26.0   40.7 52.3  
Comprehensive income 5.8 26.9   43.1 54.1  
Consolidating Adjustments            
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME            
Net sales (20.5) (20.0)   (41.3) (38.9)  
Cost of products sold:            
Cost of products sold, excluding depreciation and amortization and other items (19.6) (19.1)   (39.7) (37.3)  
Lower of cost or market inventory write-down         0.0  
Unrealized loss (gain) on derivative instruments 0.0 0.0   0.0 0.0  
Depreciation and amortization 0.0 0.0   0.0 0.0  
Selling, general, administrative, research and development (0.5) (0.9)   (1.0) (1.4)  
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0   0.0 0.0  
Gain on removal of Union VEBA net assets       0.0 0.0  
Total selling, general, administrative, research and development (0.5) (0.9)   (1.0) (1.4)  
Goodwill impairment 0.0     0.0    
Other operating charges, net   0.0     0.0  
Total costs and expenses (20.1) (20.0)   (40.7) (38.7)  
Operating income (0.4) 0.0   (0.6) (0.2)  
Other (expense) income:            
Interest (expense) income 0.0 0.0   0.0 0.0  
Other (expense) income, net 0.0 0.0   0.0 0.0  
Income before income taxes (0.4) 0.0   (0.6) (0.2)  
Income tax provision 2.3 7.1   4.8 9.1  
Earnings in equity of subsidiaries (11.4) (44.8)   (54.6) (76.5)  
Net income (9.5) (37.7)   (50.4) (67.6)  
Comprehensive income (10.6) (38.6)   (52.8) (69.4)  
Parent            
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME            
Net sales 0.0 0.0   0.0 0.0  
Cost of products sold:            
Cost of products sold, excluding depreciation and amortization and other items 0.0 0.0   0.0 0.0  
Lower of cost or market inventory write-down         0.0  
Unrealized loss (gain) on derivative instruments 0.0 0.0   0.0 0.0  
Depreciation and amortization 0.0 0.0   0.0 0.0  
Selling, general, administrative, research and development 1.5 1.6   2.4 2.4  
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0   0.0 0.0  
Gain on removal of Union VEBA net assets       0.0 0.0  
Total selling, general, administrative, research and development 1.5 1.6   2.4 2.4  
Goodwill impairment 0.0     0.0    
Other operating charges, net   0.0     0.0  
Total costs and expenses 1.5 1.6   2.4 2.4  
Operating income (1.5) (1.6)   (2.4) (2.4)  
Other (expense) income:            
Interest (expense) income (4.6) (5.9)   (10.3) (10.2)  
Other (expense) income, net 0.0 (11.0)   0.0 (11.0)  
Income before income taxes (6.1) (18.5)   (12.7) (23.6)  
Income tax provision 0.0 0.0   0.0 0.0  
Earnings in equity of subsidiaries 10.8 44.5   53.4 75.9  
Net income 4.7 26.0   40.7 52.3  
Comprehensive income 5.8 26.9   43.1 54.1  
Guarantor Subsidiaries            
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME            
Net sales 347.0 327.3   693.8 663.0  
Cost of products sold:            
Cost of products sold, excluding depreciation and amortization and other items 271.6 246.0   544.2 503.1  
Lower of cost or market inventory write-down         4.9  
Unrealized loss (gain) on derivative instruments 11.9 (10.9)   (3.2) (14.9)  
Depreciation and amortization 9.0 8.5   18.0 16.7  
Selling, general, administrative, research and development 22.8 23.8   43.7 47.4  
Net periodic postretirement benefit cost relating to Salaried VEBA 1.1 0.9   2.2 1.7  
Gain on removal of Union VEBA net assets       (1.3) (0.1)  
Total selling, general, administrative, research and development 23.9 24.7   44.6 49.0  
Goodwill impairment 18.4     18.4    
Other operating charges, net   0.1     0.1  
Total costs and expenses 334.8 268.4   622.0 558.9  
Operating income 12.2 58.9   71.8 104.1  
Other (expense) income:            
Interest (expense) income (0.9) 0.4   (0.8) 1.0  
Other (expense) income, net 0.8 0.2   1.4 0.5  
Income before income taxes 12.1 59.5   72.4 105.6  
Income tax provision (4.2) (22.6)   (25.0) (39.5)  
Earnings in equity of subsidiaries 0.6 0.3   1.2 0.6  
Net income 8.5 37.2   48.6 66.7  
Comprehensive income 9.6 38.1   51.0 68.4  
Non-Guarantor Subsidiaries            
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME            
Net sales 29.8 27.6   59.1 54.0  
Cost of products sold:            
Cost of products sold, excluding depreciation and amortization and other items 25.7 23.5   51.0 46.6  
Lower of cost or market inventory write-down         0.0  
Unrealized loss (gain) on derivative instruments 0.0 0.0   0.0 0.0  
Depreciation and amortization 0.5 0.5   1.1 1.0  
Selling, general, administrative, research and development 2.5 3.0   4.9 5.2  
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0   0.0 0.0  
Gain on removal of Union VEBA net assets       0.0 0.0  
Total selling, general, administrative, research and development 2.5 3.0   4.9 5.2  
Goodwill impairment 0.0     0.0    
Other operating charges, net   0.0     0.0  
Total costs and expenses 28.7 27.0   57.0 52.8  
Operating income 1.1 0.6   2.1 1.2  
Other (expense) income:            
Interest (expense) income 0.0 0.0   0.0 0.0  
Other (expense) income, net 0.2 0.1   0.2 0.1  
Income before income taxes 1.3 0.7   2.3 1.3  
Income tax provision (0.3) (0.2)   (0.5) (0.4)  
Earnings in equity of subsidiaries 0.0 0.0   0.0 0.0  
Net income 1.0 0.5   1.8 0.9  
Comprehensive income $ 1.0 $ 0.5   $ 1.8 $ 1.0